Literature DB >> 33236288

Nerve Growth Factor is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice.

Zhenzhen Xu1,2, Jianxiang Jiang1, Shengyuan Xu1, Zunchun Xie2, Pei He1, Shishi Jiang1, Renshi Xu3.   

Abstract

Nerve growth factor (NGF) is a protective factor of neural cells; the possible relationship between the NGF and the pathogenesis of amyotrophic lateral sclerosis (ALS) hasn't been completely known. In this study, we observed and analyzed the expression and distribution of NGF, as well as the possible relationship between the NGF expression and distribution and the neural cell death in both SOD1 wild-type (WT) and Tg(SOD1*G93A)1Gur (TG) mice applying the fluorescence immunohistochemistry method. The results showed that the expression and distribution of NGF in the anterior horn (AH), the lateral horn (LH), and the surrounding central canal (CC) significantly increased at the supper early stage of ALS (Pre-onset stage) and the early stage (Onset stage), but the NGF expression and distribution in the AH, the LH, and the surrounding CC significantly reduced at the progression stage. The astrocyte, neuron, and oligodendrocyte produced the NGF and the neural precursor cells (NPCs) produced the NGF. The neural cell death gradually increased accompanying with the reduction of NGF expression and distribution. Our data suggested that the NGF was a protective factor of neural cells, because the neural cells in the AH, the LH, and the surrounding CC produced more NGF at the supper early and early stage of ALS; moreover, the NPCs produced the NGF. It implied that the NGF exerted the protective effect of neural cells, prevented from the neural cell death and aroused the potential of self-repair in the development of ALS.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Nerve growth factor; Pathogenesis; Spinal cord; Tg(SOD1*G93A)1Gur mice

Mesh:

Substances:

Year:  2020        PMID: 33236288     DOI: 10.1007/s10571-020-00993-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  57 in total

Review 1.  Neurotrophins: more to NGF than just survival.

Authors:  A M Davies
Journal:  Curr Biol       Date:  2000-05-18       Impact factor: 10.834

2.  No re-expression of high-affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis.

Authors:  S M Aquilonius; H Askmark; T Ebendal; P G Gillberg
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

Review 3.  Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis.

Authors:  Lucia Chico; Martina Modena; Annalisa Lo Gerfo; Giulia Ricci; Elena Caldarazzo Ienco; Larisa Ryskalin; Francesco Fornai; Gabriele Siciliano
Journal:  Arch Ital Biol       Date:  2017-12-01       Impact factor: 1.000

Review 4.  Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics.

Authors:  Ranjeet Prasad Dash; R Jayachandra Babu; Nuggehally R Srinivas
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

5.  Creatine affords protection against glutamate-induced nitrosative and oxidative stress.

Authors:  Mauricio P Cunha; Vicente Lieberknecht; Ana Belén Ramos-Hryb; Gislaine Olescowicz; Fabiana K Ludka; Carla I Tasca; Nelson H Gabilan; Ana Lúcia S Rodrigues
Journal:  Neurochem Int       Date:  2016-01-19       Impact factor: 3.921

Review 6.  Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications.

Authors:  Ruth Chia; Adriano Chiò; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2017-11-16       Impact factor: 44.182

Review 7.  The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease.

Authors:  L W Chen; K K L Yung; Y S Chan; D K Y Shum; J P Bolam
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-12       Impact factor: 4.388

Review 8.  The glutamate hypothesis in ALS: pathophysiology and drug development.

Authors:  H Blasco; S Mavel; P Corcia; P H Gordon
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 9.  The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.

Authors:  Nadia Canu; Giuseppina Amadoro; Viviana Triaca; Valentina Latina; Valentina Sposato; Veronica Corsetti; Cinzia Severini; Maria Teresa Ciotti; Pietro Calissano
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

Review 10.  Mechanisms of protein toxicity in neurodegenerative diseases.

Authors:  Chang Geon Chung; Hyosang Lee; Sung Bae Lee
Journal:  Cell Mol Life Sci       Date:  2018-06-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.